CRLBF
Price
$1.20
Change
+$0.06 (+5.26%)
Updated
Sep 5 closing price
Capitalization
424.65M
61 days until earnings call
MRMD
Price
$0.16
Change
-$0.01 (-5.88%)
Updated
Sep 5 closing price
Capitalization
61M
59 days until earnings call
Interact to see
Advertisement

CRLBF vs MRMD

Header iconCRLBF vs MRMD Comparison
Open Charts CRLBF vs MRMDBanner chart's image
Cresco Labs
Price$1.20
Change+$0.06 (+5.26%)
Volume$613.99K
Capitalization424.65M
MariMed
Price$0.16
Change-$0.01 (-5.88%)
Volume$1.6M
Capitalization61M
CRLBF vs MRMD Comparison Chart in %
Loading...
CRLBF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MRMD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CRLBF vs. MRMD commentary
Sep 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CRLBF is a Hold and MRMD is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 07, 2025
Stock price -- (CRLBF: $1.20 vs. MRMD: $0.16)
Brand notoriety: CRLBF and MRMD are both not notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: CRLBF: 49% vs. MRMD: 113%
Market capitalization -- CRLBF: $424.65M vs. MRMD: $61M
CRLBF [@Pharmaceuticals: Generic] is valued at $424.65M. MRMD’s [@Pharmaceuticals: Generic] market capitalization is $61M. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $67.95B to $0. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $3.93B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CRLBF’s FA Score shows that 0 FA rating(s) are green whileMRMD’s FA Score has 0 green FA rating(s).

  • CRLBF’s FA Score: 0 green, 5 red.
  • MRMD’s FA Score: 0 green, 5 red.
According to our system of comparison, MRMD is a better buy in the long-term than CRLBF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CRLBF’s TA Score shows that 4 TA indicator(s) are bullish while MRMD’s TA Score has 4 bullish TA indicator(s).

  • CRLBF’s TA Score: 4 bullish, 4 bearish.
  • MRMD’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, both CRLBF and MRMD are a good buy in the short-term.

Price Growth

CRLBF (@Pharmaceuticals: Generic) experienced а -20.37% price change this week, while MRMD (@Pharmaceuticals: Generic) price change was +0.97% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was +0.10%. For the same industry, the average monthly price growth was +12.13%, and the average quarterly price growth was +87.01%.

Reported Earning Dates

CRLBF is expected to report earnings on Nov 07, 2025.

MRMD is expected to report earnings on Nov 05, 2025.

Industries' Descriptions

@Pharmaceuticals: Generic (+0.10% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CRLBF($425M) has a higher market cap than MRMD($61M). MRMD YTD gains are higher at: 34.283 vs. CRLBF (31.330). CRLBF has higher annual earnings (EBITDA): 136M vs. MRMD (11.9M). CRLBF has more cash in the bank: 147M vs. MRMD (5.94M). MRMD has less debt than CRLBF: MRMD (87M) vs CRLBF (631M). CRLBF has higher revenues than MRMD: CRLBF (685M) vs MRMD (157M).
CRLBFMRMDCRLBF / MRMD
Capitalization425M61M697%
EBITDA136M11.9M1,143%
Gain YTD31.33034.28391%
P/E RatioN/AN/A-
Revenue685M157M436%
Total Cash147M5.94M2,476%
Total Debt631M87M725%
FUNDAMENTALS RATINGS
CRLBF vs MRMD: Fundamental Ratings
CRLBF
MRMD
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
79
Overvalued
59
Fair valued
PROFIT vs RISK RATING
1..100
10099
SMR RATING
1..100
9496
PRICE GROWTH RATING
1..100
3536
P/E GROWTH RATING
1..100
10097
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

MRMD's Valuation (59) in the null industry is in the same range as CRLBF (79). This means that MRMD’s stock grew similarly to CRLBF’s over the last 12 months.

MRMD's Profit vs Risk Rating (99) in the null industry is in the same range as CRLBF (100). This means that MRMD’s stock grew similarly to CRLBF’s over the last 12 months.

CRLBF's SMR Rating (94) in the null industry is in the same range as MRMD (96). This means that CRLBF’s stock grew similarly to MRMD’s over the last 12 months.

CRLBF's Price Growth Rating (35) in the null industry is in the same range as MRMD (36). This means that CRLBF’s stock grew similarly to MRMD’s over the last 12 months.

MRMD's P/E Growth Rating (97) in the null industry is in the same range as CRLBF (100). This means that MRMD’s stock grew similarly to CRLBF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CRLBFMRMD
RSI
ODDS (%)
Bearish Trend 3 days ago
76%
Bearish Trend 3 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
90%
Bearish Trend 3 days ago
90%
Momentum
ODDS (%)
N/A
Bullish Trend 3 days ago
83%
MACD
ODDS (%)
Bearish Trend 3 days ago
82%
Bullish Trend 3 days ago
80%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
89%
Bullish Trend 3 days ago
80%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
81%
Bullish Trend 3 days ago
78%
Advances
ODDS (%)
Bullish Trend 10 days ago
83%
Bullish Trend 6 days ago
80%
Declines
ODDS (%)
Bearish Trend 4 days ago
89%
Bearish Trend 3 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
81%
Aroon
ODDS (%)
Bullish Trend 3 days ago
83%
Bullish Trend 3 days ago
76%
View a ticker or compare two or three
Interact to see
Advertisement
CRLBF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MRMD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SYHBF0.290.02
+5.65%
Skyharbour Resources Ltd.
FANUF28.170.56
+2.05%
Fanuc Corporation
SLFPF2.570.04
+1.78%
ABERDEEN GROUP PLC
IPZYF0.68N/A
N/A
IP Group PLC
NROM0.21N/A
N/A
Noble Roman's, Inc.

CRLBF and

Correlation & Price change

A.I.dvisor indicates that over the last year, CRLBF has been closely correlated with TSNDF. These tickers have moved in lockstep 76% of the time. This A.I.-generated data suggests there is a high statistical probability that if CRLBF jumps, then TSNDF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CRLBF
1D Price
Change %
CRLBF100%
+5.26%
TSNDF - CRLBF
76%
Closely correlated
+13.08%
CURLF - CRLBF
76%
Closely correlated
+1.79%
TCNNF - CRLBF
75%
Closely correlated
+4.55%
JUSHF - CRLBF
74%
Closely correlated
+6.59%
VRNOF - CRLBF
73%
Closely correlated
+5.51%
More

MRMD and

Correlation & Price change

A.I.dvisor indicates that over the last year, MRMD has been loosely correlated with TSNDF. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if MRMD jumps, then TSNDF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MRMD
1D Price
Change %
MRMD100%
-8.53%
TSNDF - MRMD
45%
Loosely correlated
+13.08%
JUSHF - MRMD
43%
Loosely correlated
+6.59%
TCNNF - MRMD
41%
Loosely correlated
+4.55%
CRLBF - MRMD
40%
Loosely correlated
+5.26%
ACB - MRMD
39%
Loosely correlated
+1.66%
More